Literature DB >> 25419348

Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and -6 in prostate cancer.

Ning Chi1, Zhaohui Tan1, Kewei Ma1, Lidao Bao2, Zhizhong Yun1.   

Abstract

AIM: Myeloid-derived suppressor cells (MDSCs) are a population of cells which negatively regulate immune response during tumor progression. In this study, we assessed the accumulation of MDSCs (CD33(+)CD11b(+)HLA-DR(-)CD14(-)) in patients with prostate cancer and its clinical relevance.
METHODS: We tested the frequency of MDSCs in the peripheral blood of patients with prostate cancer or benign prostate hyperplasia and healthy donors. Serumal interleukin-8, -6 and -10 were analyzed. Effects of MDSCs on the T cell response were determined.
RESULTS: MDSCs increased in cancer patients, and there was an association between MDSCs and cancer stages or overall survival. Elevated serumal interleukin-8 and -6 in cancer patients correlated with MDSCs. Moreover, accumulation of MDSCs was associated with defective T cell function.
CONCLUSION: Our study showed an increased population of MDSCs in patients with prostate cancer. Interleukin-8 and -6 in serum may play a new important role companied with MDSCs in prostate cancer.

Entities:  

Keywords:  IL-6; IL-8; MDSCs; prostate cancer

Year:  2014        PMID: 25419348      PMCID: PMC4238489     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  30 in total

Review 1.  Myeloid-derived suppressor cells in transplantation and cancer.

Authors:  Jordi C Ochando; Shu Hsia Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

2.  Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

Authors:  Rachel F Gabitass; Nicola E Annels; Deborah D Stocken; Hardev A Pandha; Gary W Middleton
Journal:  Cancer Immunol Immunother       Date:  2011-06-05       Impact factor: 6.968

Review 3.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

4.  Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy.

Authors:  Bethany L Mundy-Bosse; Gregory S Young; Todd Bauer; Elaine Binkley; Mark Bloomston; Matthew A Bill; Tanios Bekaii-Saab; William E Carson; Gregory B Lesinski
Journal:  Cancer Immunol Immunother       Date:  2011-05-21       Impact factor: 6.968

5.  Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.

Authors:  Zibing Wang; Yong Zhang; Yuqing Liu; Li Wang; Lingdi Zhao; Tiejun Yang; Chaohong He; Yongping Song; Quanli Gao
Journal:  J Immunother       Date:  2014-01       Impact factor: 4.456

6.  Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: profile comparison.

Authors:  Davide Brusa; Mariagrazia Simone; Paolo Gontero; Rosella Spadi; Patrizia Racca; Jasmin Micari; Maurizio Degiuli; Sara Carletto; Alessandro Tizzani; Lina Matera
Journal:  Int J Urol       Date:  2013-02-20       Impact factor: 3.369

7.  Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.

Authors:  Paulo C Rodriguez; David G Quiceno; Jovanny Zabaleta; Blair Ortiz; Arnold H Zea; Maria B Piazuelo; Alberto Delgado; Pelayo Correa; Jason Brayer; Eduardo M Sotomayor; Scott Antonia; Juan B Ochoa; Augusto C Ochoa
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

8.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

Review 9.  Myeloid derived suppressor cells and their role in diseases.

Authors:  Y Y Kong; M Fuchsberger; S D Xiang; V Apostolopoulos; M Plebanski
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

10.  Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.

Authors:  Maciej Kujawski; Marcin Kortylewski; Heehyoung Lee; Andreas Herrmann; Heidi Kay; Hua Yu
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

View more
  31 in total

1.  NUDT11 rs5945572 polymorphism and prostate cancer risk: a meta-analysis.

Authors:  Wencheng Li; Min Gu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.

Authors:  Charli Dominguez; Justin M David; Claudia Palena
Journal:  Semin Cancer Biol       Date:  2017-08-18       Impact factor: 15.707

Review 3.  Tumor Plasticity and Resistance to Immunotherapy.

Authors:  Lucas A Horn; Kristen Fousek; Claudia Palena
Journal:  Trends Cancer       Date:  2020-03-04

Review 4.  A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.

Authors:  Christopher Shipp; Lisa Speigl; Nicole Janssen; Alexander Martens; Graham Pawelec
Journal:  Cell Mol Life Sci       Date:  2016-05-28       Impact factor: 9.261

5.  Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.

Authors:  Irina Lerman; Maria de la Luz Garcia-Hernandez; Javier Rangel-Moreno; Luis Chiriboga; Chunliu Pan; Kent L Nastiuk; John J Krolewski; Aritro Sen; Stephen R Hammes
Journal:  Mol Cancer Res       Date:  2017-05-16       Impact factor: 5.852

6.  Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.

Authors:  Xin Long; Jian Wang; Jian-Ping Zhao; Hui-Fang Liang; Peng Zhu; Qi Cheng; Qian Chen; Yan-Hui Wu; Zhan-Guo Zhang; Bi-Xiang Zhang; Xiao-Ping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

Review 7.  Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies.

Authors:  Peng-Fei Wang; Si-Ying Song; Ting-Jian Wang; Wen-Jun Ji; Shou-Wei Li; Ning Liu; Chang-Xiang Yan
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110

Review 8.  Targeting interleukin-6 for noninfectious uveitis.

Authors:  Phoebe Lin
Journal:  Clin Ophthalmol       Date:  2015-09-11

Review 9.  Prostate carcinogenesis: inflammatory storms.

Authors:  Johann S de Bono; Christina Guo; Bora Gurel; Angelo M De Marzo; Karen S Sfanos; Ram S Mani; Jesús Gil; Charles G Drake; Andrea Alimonti
Journal:  Nat Rev Cancer       Date:  2020-06-16       Impact factor: 60.716

10.  Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.

Authors:  Niall M Corcoran; Anthony T Papenfuss; Christopher M Hovens; Stefano Mangiola; Patrick McCoy; Martin Modrak; Fernando Souza-Fonseca-Guimaraes; Daniel Blashki; Ryan Stuchbery; Simon P Keam; Michael Kerger; Ken Chow; Chayanica Nasa; Melanie Le Page; Natalie Lister; Simon Monard; Justin Peters; Phil Dundee; Scott G Williams; Anthony J Costello; Paul J Neeson; Bhupinder Pal; Nicholas D Huntington
Journal:  BMC Cancer       Date:  2021-07-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.